S&P 500 struggles for direction as investor await inflation data
DUBLIN - Investment firm Geode Capital Management, LLC disclosed Friday it holds a 2.24% stake in Avadel Pharmaceuticals plc, according to a regulatory filing with the Irish Takeover Panel.
The disclosure, made under Rule 8.3 of the Irish Takeover Panel Act, reveals Geode owns and controls 2,186,412 ordinary shares of Avadel Pharmaceuticals as of November 6, 2025.
The filing also details recent transactions, showing Geode purchased 1,692 shares at $18.71 per unit while selling 6,322 shares at the same price.
The disclosure is required under Irish regulations for entities holding interests of 1% or more in companies involved in potential takeover situations, though the filing does not specify details about any pending offer for Avadel.
Avadel Pharmaceuticals is a biopharmaceutical company headquartered in Ireland with operations focused on developing medications using its drug delivery technologies.
The statement confirms Geode has no indemnity arrangements, options, or other agreements relating to Avadel securities that might influence dealing decisions.
This information was provided in a Form 8.3 filing, which is a standard disclosure document required by the Irish Takeover Panel for significant shareholders during offer periods.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.